The interim analysis was always expected to be after the expiry date of the options.
I sold $75K in PAR shares @ 50c to buy $42K in PAROA @ 15c, which means if by February 2026 PAR's share price is below 22c or above ~76c (assuming σ_PBO=100%), I'll be better off than if I'd held onto my PAR shares.
Unlike you I don't believe there is a "well over 50% chance" that the share price will be under ~60c in February 2026...
I don't understand why you, Gan_Gans, and m9 remain PAR shareholders when you think PAR have almost no chance of doing a deal. Do you really think that PAR can fund the trial through to Interim Analysis by doing capital raises at sub 20c? Even issuing 100M shares at 20c will only raise A$20M.
- Forums
- ASX - By Stock
- PAR
- Ann: Notice of General Meeting/Proxy Form
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
4.69%
!
30.5¢

Ann: Notice of General Meeting/Proxy Form, page-35
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.5¢ |
Change
-0.015(4.69%) |
Mkt cap ! $118.7M |
Open | High | Low | Value | Volume |
32.0¢ | 32.0¢ | 30.0¢ | $155.3K | 501.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6563 | 30.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 96132 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 65954 | 0.300 |
3 | 117880 | 0.295 |
13 | 307711 | 0.290 |
6 | 99663 | 0.285 |
16 | 298345 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 96132 | 4 |
0.315 | 10393 | 2 |
0.320 | 39009 | 6 |
0.325 | 25409 | 3 |
0.330 | 10 | 1 |
Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |